Data coverage, completeness and provenance for Mesoblast in the Stock Market API — Health Care · Biotechnology.
Mesoblast Limited, together with its subsidiaries, engages in the development and commercialisation of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company's proprietary regenerative medicine technology platform is based on specialised cells known as mesenchymal lineage cells. It markets Ryoncil (remestemcel-L-rknd) for steroid-refractory acute graft-versus-host disease in paediatric patients (FDA approved December 2024) and has further Phase III programs including remestemcel-L for inflammatory bowel disease, chronic heart failure, and chronic low back pain due to degenerative disc disease. It has strategic partnerships with Tasly Pharmaceutical Group, JCR Pharmaceuticals, and Grunenthal. Mesoblast was incorporated in 2004 and is headquartered in Melbourne, Australia.
HQ: Melbourne, VIC · Employees: 108 · Website: https://www.mesoblast.com · Profile fields populated: 100%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/MSB/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 | 2026-06-30 | 30 | yfinance | ||||
| FY2025 | 2025-06-30 | 33 | yfinance | ||||
| FY2024 | 2024-06-30 | 33 | yfinance | ||||
| FY2023 | 2023-06-30 | 32 | yfinance | ||||
| FY2022 | 2022-06-30 | 4 | yfinance |
Every number on this page is one API call away. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/MSB
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/MSB/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/MSB/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/MSB/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/MSB/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/MSB
Free tier — instant API key. Built for AI agents.